Projects
Identification of genetic markers for everolimus-resistance in patients with pancreatic neuroendocrine tumors. University of Antwerp
Identification of genetic markers for everolimus-resistance in patients with pancreatic neuroendocrine tumors University of Antwerp
Salmonella biofilm formation in chronic carrier pigs: impact on gut colonization, genetic markers for functional diagnostics and potential as target for non-antibiotic therapy KU Leuven
Salmonella biofilm formation in chronic carrier pigs: impact on gut colonization, genetic markers for functional diagnostics and potential as target for non-antibiotic therapy KU Leuven
The goal of this project is to expand the knowledge on the role of Salmonella biofilm in pig farming. In a first subgoal we aim to investigate Salmonella biofilm formation as a strong contributor to its chronic colonization in the pig gut. In a second subgoal we aim to identify genetic markers for the capacity of biofilm formation. These markers can be included in fuctional diagnostic tools that focus on a phenotypic functional feature of ...
Efficiently tracing fraud and illegal fisheries using genetic markers (aimed at food safety and sustainable exploitation). KU Leuven
In this project we will develop a forensic tool which can serve as proof for illegal, unreported and unregulated (IUU) products, ...
Predictive genetic markers in gynaecological cancers: how to improve targeted therapy. KU Leuven
The development of more targeted therapies opened up a completely new era in treatment of gynaecological malignancies. However, little is known about the ideal position and timing in the treatment strategy and which patients in particular will benefit from treatments such as poly (ADP-ribose) polymerase inhibitors (PARPi) and immune checkpoint blockade (ICB). The aim of this proposal is to find (epi-)genetic markers that predict response to ...
Predictive genetic markers for targeted therapy in gynaecological malignancies: bridging the gap between “one-size-fits-all” and more personalised treatment approach. KU Leuven
Even with today’s ongoing progress in diagnosis and treatment options, HGSOC is still characterized by poor long-term survival and high recurrence rates. Platinum-based chemotherapy and surgery are key in the treatment but development of resistance remains a major clinical problem. Recently, more targeted therapies, such as PARPi have been developed which could help to turn around the ‘one-chemo-fits-all’ approach. This breakthrough can have ...